| |
| |
|
| Insider
Information: |
Rankin Aubrey |
| Relationship: |
Director |
| City: |
Newark |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
94,091 |
|
|
Indirect Shares
|
475,913 |
|
|
| Direct
Value |
$319,909 |
|
|
|
Indirect Value
|
$1,618,104 |
|
|
| Total
Shares |
570,004 |
|
|
| Total
Value |
$1,938,014 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Revance Therapeutics, Inc. |
RVNC |
Director |
2022-03-15 |
94,091 |
2022-03-15 |
475,913 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RVNC |
Revance Therapeutics, Inc... |
Director |
– • – |
2022-03-15 |
4 |
D |
$15.79 |
$21,664 |
D/D |
(1,372) |
94,091 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
President, Innovation & Tech |
• • – |
2021-12-03 |
4 |
B |
$14.43 |
$432,876 |
D/D |
30,000 |
95,463 |
2.81 |
% |
|
| RVNC |
Revance Therapeutics, Inc... |
President, Innovation & Tech |
• • – |
2021-08-16 |
4 |
AS |
$26.34 |
$246,659 |
D/D |
(9,364) |
65,463 |
0 |
% |
|
| RVNC |
Revance Therapeutics, Inc... |
President, Innovation & Tech |
• • – |
2021-08-15 |
4 |
D |
$26.02 |
$128,773 |
D/D |
(4,949) |
74,827 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
President, Innovation & Tech |
• • – |
2021-07-28 |
4 |
AS |
$30.00 |
$1,632,960 |
I/I |
(54,332) |
154,302 |
0 |
% |
|
| RVNC |
Revance Therapeutics, Inc... |
President, Innovation & Tech |
• • – |
2021-07-26 |
4 |
AS |
$29.72 |
$1,645,953 |
I/I |
(55,382) |
355,943 |
0 |
% |
|
| RVNC |
Revance Therapeutics, Inc... |
President, Innovation & Tech |
• • – |
2021-03-04 |
4 |
AS |
$25.43 |
$842,216 |
I/I |
(33,119) |
411,327 |
0 |
% |
|
| RVNC |
Revance Therapeutics, Inc... |
President, Innovation & Tech |
• • – |
2021-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
11,905 |
79,776 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
President, Innovation & Tech |
• • – |
2021-02-01 |
4 |
AS |
$25.95 |
$859,438 |
I/I |
(33,119) |
444,446 |
0 |
% |
|
| RVNC |
Revance Therapeutics, Inc... |
President, Innovation & Tech |
• • – |
2020-11-30 |
4 |
AS |
$23.85 |
$789,888 |
I/I |
(33,119) |
510,684 |
0 |
% |
|
| RVNC |
Revance Therapeutics, Inc... |
President, Innovation & Tech |
• • – |
2020-10-29 |
4 |
AS |
$26.15 |
$865,949 |
I/I |
(33,119) |
543,803 |
0 |
% |
|
| RVNC |
Revance Therapeutics, Inc... |
President, Innovation & Tech |
• • – |
2020-09-28 |
4 |
AS |
$26.18 |
$867,055 |
I/I |
(33,119) |
576,922 |
0 |
% |
|
| RVNC |
Revance Therapeutics, Inc... |
President, Innovation & Tech |
• • – |
2020-07-23 |
4/A |
A |
$0.00 |
$0 |
I/I |
610,041 |
610,041 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
President, Innovation & Tech |
• • – |
2020-07-23 |
4/A |
A |
$0.00 |
$0 |
D/D |
57,251 |
67,871 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
President, Innovation & TechOf |
• • – |
2020-07-23 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
261,453 |
|
% |
|
| RVNC |
Revance Therapeutics, Inc... |
President, Innovation & TechOf |
• • – |
2020-07-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,620 |
|
% |
|
| RVNC |
Revance Therapeutics, Inc... |
President, Innovation & Tech |
• • – |
2020-07-23 |
4 |
A |
$0.00 |
$0 |
D/D |
667,292 |
667,292 |
0 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
